| Followers | 9 |
| Posts | 3235 |
| Boards Moderated | 0 |
| Alias Born | 04/21/2025 |
Wednesday, September 24, 2025 4:03:26 PM
UPDATED:
She sold cognate way to early (not sure if some proceeds went back into NWBO) , salaries don't equal net worth (after tax, that is her spending money) , and Toucan's main holding is Advent.. We have no idea what that is worth, probably not much if she's gonna merge it into NWBio. Which I still doubt.
Finally I have no knowledge of her ex husband or what she got in the divorce.
PS, you can basically subtract her net worth in NWBO shares... That is going nowhere but down, likely close to zero. Inmune has almost no future either. IMO
"No, Linda Powers did not get all the proceeds from the Cognate BioServices sale in 2018. The 2018 transaction was a management buyout of Cognate BioServices, backed by investors including Tennenbaum Capital Partners and Medivate Partners. Linda Powers, through Toucan Capital, had previously controlled Cognate but relinquished ownership and her board role in this buyout. The proceeds from the buyout would have been distributed among Toucan Capital and other stakeholders involved, based on their ownership stakes at the time, with the new investors (Tennenbaum, Medivate, and management) taking control. Specific details on the financial split are not publicly disclosed in available records.Thus, while Powers likely received some proceeds through Toucan’s stake, she did not receive all of them, as the buyout involved multiple parties."
Per Grok
She sold cognate way to early (not sure if some proceeds went back into NWBO) , salaries don't equal net worth (after tax, that is her spending money) , and Toucan's main holding is Advent.. We have no idea what that is worth, probably not much if she's gonna merge it into NWBio. Which I still doubt.
Finally I have no knowledge of her ex husband or what she got in the divorce.
PS, you can basically subtract her net worth in NWBO shares... That is going nowhere but down, likely close to zero. Inmune has almost no future either. IMO
"No, Linda Powers did not get all the proceeds from the Cognate BioServices sale in 2018. The 2018 transaction was a management buyout of Cognate BioServices, backed by investors including Tennenbaum Capital Partners and Medivate Partners. Linda Powers, through Toucan Capital, had previously controlled Cognate but relinquished ownership and her board role in this buyout. The proceeds from the buyout would have been distributed among Toucan Capital and other stakeholders involved, based on their ownership stakes at the time, with the new investors (Tennenbaum, Medivate, and management) taking control. Specific details on the financial split are not publicly disclosed in available records.Thus, while Powers likely received some proceeds through Toucan’s stake, she did not receive all of them, as the buyout involved multiple parties."
Per Grok
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
